Heparan sulphate binding controls in vivo half-life of the HpARI protein family
Florent Colomb,
Abhishek Jamwal,
Adefunke Ogunkanbi,
Tania Frangova,
Alice R Savage,
Sarah Kelly,
Gavin J Wright,
Matthew K Higgins,
Henry J McSorley
Affiliations
Florent Colomb
Division of Cell Signalling and Immunology, School of Life Sciences, University of Dundee, Dundee, United Kingdom
Abhishek Jamwal
Department of Biochemistry, University of Oxford, Oxford, United Kingdom; Kavli Institute of Nanoscience Discovery, Dorothy-Crowfoot Hodgkin Building, University of Oxford, Oxford, United Kingdom
Adefunke Ogunkanbi
Division of Cell Signalling and Immunology, School of Life Sciences, University of Dundee, Dundee, United Kingdom; Department of Biology, Hull York Medical School, York Biomedical Research Institute, University of York, York, United Kingdom
Tania Frangova
Division of Cell Signalling and Immunology, School of Life Sciences, University of Dundee, Dundee, United Kingdom
Alice R Savage
Division of Cell Signalling and Immunology, School of Life Sciences, University of Dundee, Dundee, United Kingdom
Sarah Kelly
Division of Cell Signalling and Immunology, School of Life Sciences, University of Dundee, Dundee, United Kingdom
Department of Biochemistry, University of Oxford, Oxford, United Kingdom; Kavli Institute of Nanoscience Discovery, Dorothy-Crowfoot Hodgkin Building, University of Oxford, Oxford, United Kingdom
The parasitic nematode Heligmosomoides polygyrus bakeri secretes the HpARI family, which bind to IL-33, either suppressing (HpARI1 and HpARI2) or enhancing (HpARI3) responses to the cytokine. We previously showed that HpARI2 also bound to DNA via its first complement control protein (CCP1) domain. Here, we find that HpARI1 can also bind DNA, while HpARI3 cannot. Through the production of HpARI2/HpARI3 CCP1 domain-swapped chimeras, DNA-binding ability can be transferred, and correlates with in vivo half-life of administered proteins. We found that HpARI1 and HpARI2 (but not HpARI3) also binds to the extracellular matrix component heparan sulphate (HS), and structural modelling showed a basic charged patch in the CCP1 domain of HpARI1 and HpARI2 (but not HpARI3) which could facilitate these interactions. Finally, a mutant of HpARI2 was produced which lacked DNA and HS binding, and was also shown to have a short half-life in vivo. Therefore, we propose that during infection the suppressive HpARI1 and HpARI2 proteins have long-lasting effects at the site of deposition due to DNA and/or extracellular matrix interactions, while HpARI3 has a shorter half-life due to a lack of these interactions.